A machine learning-derived composite biomarker built from twelve routine clinical measurements predicted waitlist mortality ...
One study from 2020 showed that women were 8.6 percent more likely than men to die waiting for a liver transplant and 14.4 ...
Morgen, zaterdag, weer de VoetbalScore, met live de tussenstanden van de competitie- en bekerwedstrijden. Wil jij bijdragen aan onze VoetbalScore? Meld je dan aan via onderstaand formulier. Na je ...
Living with advanced liver disease can involve regular tests, changing symptoms, and important treatment decisions. Doctors need a consistent way to assess disease severity and determine how urgently ...
Hepatocellular carcinoma, the most common primary cancer of the liver, remains one of the leading causes of cancer-related death both in Taiwan and around the world, and the clinical dilemma it poses ...
National OPTN analysis (2010–2023) matched 14,861 MASH candidates 1:1 by MELD, year, sex, age, and region, showing a near-tripling of MASH listings over time. Despite identical listing MELD (18.0), ...
Bilirubin interference in the widely used Jaffe creatinine assay led to artificially elevated Model for End-Stage Liver Disease (MELD) scores in a substantial proportion of patients with end-stage ...
Real-world outcomes of trastuzumab plus chemotherapy in HER2-positive biliary tract cancers from a high-incidence region. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
HepQuant, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, is excited to announce an oral presentation at Digestive Disease Week (DDW) 2026. Presented data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results